List of Tables
Table 1. Global Central Nervous System Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Central Nervous System Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Central Nervous System Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Central Nervous System Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Central Nervous System Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Central Nervous System Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Central Nervous System Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Central Nervous System Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Central Nervous System Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Central Nervous System Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Central Nervous System Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Central Nervous System Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Central Nervous System Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Central Nervous System Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Central Nervous System Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Central Nervous System Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Central Nervous System Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Central Nervous System Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Central Nervous System Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Central Nervous System Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Central Nervous System Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Central Nervous System Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Central Nervous System Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Central Nervous System Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Central Nervous System Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Central Nervous System Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Central Nervous System Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Central Nervous System Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Central Nervous System Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Central Nervous System Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Central Nervous System Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Central Nervous System Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Central Nervous System Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Central Nervous System Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Central Nervous System Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Central Nervous System Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Central Nervous System Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Central Nervous System Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Central Nervous System Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Central Nervous System Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Central Nervous System Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Central Nervous System Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Central Nervous System Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global Central Nervous System Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global Central Nervous System Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Central Nervous System Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Central Nervous System Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Central Nervous System Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Central Nervous System Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Central Nervous System Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Central Nervous System Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global Central Nervous System Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global Central Nervous System Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global Central Nervous System Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global Central Nervous System Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Central Nervous System Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Central Nervous System Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Central Nervous System Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Central Nervous System Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Central Nervous System Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Central Nervous System Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global Central Nervous System Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. Abbvie Company Information
Table 71. Abbvie Description and Business Overview
Table 72. Abbvie Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbvie Central Nervous System Therapy Product
Table 74. Abbvie Recent Developments/Updates
Table 75. Alkermes Company Information
Table 76. Alkermes Description and Business Overview
Table 77. Alkermes Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Alkermes Central Nervous System Therapy Product
Table 79. Alkermes Recent Developments/Updates
Table 80. Allergan Company Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Allergan Central Nervous System Therapy Product
Table 84. Allergan Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Central Nervous System Therapy Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. BIAL Company Information
Table 91. BIAL Description and Business Overview
Table 92. BIAL Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. BIAL Central Nervous System Therapy Product
Table 94. BIAL Recent Developments/Updates
Table 95. Bristol-myers Squibb Company Information
Table 96. Bristol-myers Squibb Description and Business Overview
Table 97. Bristol-myers Squibb Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bristol-myers Squibb Central Nervous System Therapy Product
Table 99. Bristol-myers Squibb Recent Developments/Updates
Table 100. Eisai Company Information
Table 101. Eisai Description and Business Overview
Table 102. Eisai Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Eisai Central Nervous System Therapy Product
Table 104. Eisai Recent Developments/Updates
Table 105. Endo Pharmaceuticals Company Information
Table 106. Endo Pharmaceuticals Description and Business Overview
Table 107. Endo Pharmaceuticals Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Endo Pharmaceuticals Central Nervous System Therapy Product
Table 109. Endo Pharmaceuticals Recent Developments/Updates
Table 110. Eli Lilly and Company Company Information
Table 111. Eli Lilly and Company Description and Business Overview
Table 112. Eli Lilly and Company Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Eli Lilly and Company Central Nervous System Therapy Product
Table 114. Eli Lilly and Company Recent Developments/Updates
Table 115. Hoffmann-LA Roche Company Information
Table 116. Hoffmann-LA Roche Description and Business Overview
Table 117. Hoffmann-LA Roche Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Hoffmann-LA Roche Central Nervous System Therapy Product
Table 119. Hoffmann-LA Roche Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Central Nervous System Therapy Distributors List
Table 123. Central Nervous System Therapy Customers List
Table 124. Central Nervous System Therapy Market Trends
Table 125. Central Nervous System Therapy Market Drivers
Table 126. Central Nervous System Therapy Market Challenges
Table 127. Central Nervous System Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Central Nervous System Therapy
Figure 2. Global Central Nervous System Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System Therapy Market Share by Type: 2024 & 2031
Figure 4. Antidepressant Treatment Product Picture
Figure 5. Antipsychotic Therapy Product Picture
Figure 6. Other CNS Disorder Product Picture
Figure 7. Global Central Nervous System Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Central Nervous System Therapy Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Central Nervous System Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Central Nervous System Therapy Market Size (2020-2031) & (US$ Million)
Figure 13. Global Central Nervous System Therapy Sales (2020-2031) & (K Units)
Figure 14. Global Central Nervous System Therapy Average Price (US$/Unit) & (2020-2031)
Figure 15. Central Nervous System Therapy Report Years Considered
Figure 16. Central Nervous System Therapy Sales Share by Manufacturers in 2024
Figure 17. Global Central Nervous System Therapy Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Central Nervous System Therapy Players: Market Share by Revenue in Central Nervous System Therapy in 2024
Figure 19. Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Central Nervous System Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Central Nervous System Therapy Sales Market Share by Country (2020-2031)
Figure 22. North America Central Nervous System Therapy Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Central Nervous System Therapy Sales Market Share by Country (2020-2031)
Figure 26. Europe Central Nervous System Therapy Revenue Market Share by Country (2020-2031)
Figure 27. Germany Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Central Nervous System Therapy Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Central Nervous System Therapy Revenue Market Share by Region (2020-2031)
Figure 34. China Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Central Nervous System Therapy Sales Market Share by Country (2020-2031)
Figure 45. Latin America Central Nervous System Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Central Nervous System Therapy Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Central Nervous System Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Central Nervous System Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Central Nervous System Therapy by Type (2020-2031)
Figure 55. Global Revenue Market Share of Central Nervous System Therapy by Type (2020-2031)
Figure 56. Global Central Nervous System Therapy Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Central Nervous System Therapy by Application (2020-2031)
Figure 58. Global Revenue Market Share of Central Nervous System Therapy by Application (2020-2031)
Figure 59. Global Central Nervous System Therapy Price (US$/Unit) by Application (2020-2031)
Figure 60. Central Nervous System Therapy Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
